Go to
JCI Insight
Citations to this article
Arturo Casadevall, … , Michael J. Joyner, Liise-anne Pirofski
Published February 23, 2021
Citation Information: J Clin Invest. 2021;131(7):e148832. https://doi.org/10.1172/JCI148832.
Citation Information: J Clin Invest. 2021;131(7):e148832. https://doi.org/10.1172/JCI148832.
Abstract
Authors
Arturo Casadevall, Jeffrey P. Henderson, Michael J. Joyner, Liise-anne Pirofski
Citation information
Citations to this article (37)
| Title and authors | Publication | Year |
|---|---|---|
|
Utility of COVID-19 Seropositive Plasma as Convalescent Plasma: An Immune and Neutralization Antibody Seroprevalence Analysis in Blood Donors for Future Potential Pandemic Readiness
Jain A, Negi G, Kaur D, S V, Saxena V |
Cureus | 2024 |
|
Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.
Liang F |
Viruses | 2023 |
|
Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
McConnell SA, Sachithanandham J, Mudrak NJ, Zhu X, Farhang PA, Cordero RJ, Wear MP, Shapiro JR, Park HS, Klein SL, Tobian AA, Bloch EM, Sullivan DJ, Pekosz A, Casadevall A |
Cell Chemical Biology | 2023 |
|
Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management
Chala B, Tilaye T, Waktole G |
International journal of general medicine | 2023 |
|
Efficacy of combined COVID-19 convalescent plasma with oral RNA-dependent RNA polymerase inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial (PlasMab).
Siripongboonsitti T, Nontawong N, Tawinprai K, Suptawiwat O, Soonklang K, Poovorawan Y, Mahanonda N |
Microbiology spectrum | 2023 |
|
Exercise and Experiments of Nature.
Joyner MJ, Wiggins CC, Baker SE, Klassen SA, Senefeld JW |
Comprehensive Physiology | 2023 |
|
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
X He, X Zeng |
Drug design, development and therapy | 2022 |
|
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
D Sullivan, K Gebo, S Shoham, E Bloch, B Lau, A Shenoy, G Mosnaim, T Gniadek, Y Fukuta, B Patel, S Heath, A Levine, B Meisenberg, E Spivak, S Anjan, M Huaman, J Blair, J Currier, J Paxton, J Gerber, J Petrini, P Broderick, W Rausch, M Cordisco, J Hammel, B Greenblatt, V Cluzet, D Cruser, K Oei, M Abinante, L Hammitt, C Sutcliffe, D Forthal, M Zand, E Cachay, J Raval, S Kassaye, E Foster, M Roth, C Marshall, A Yarava, K Lane, N McBee, A Gawad, N Karlen, A Singh, D Ford, D Jabs, L Appel, D Shade, S Ehrhardt, S Baksh, O Laeyendecker, A Pekosz, S Klein, A Casadevall, A Tobian, D Hanley |
New England Journal of Medicine | 2022 |
|
Immunodominant Linear B-Cell Epitopes of SARS-CoV-2 Spike, Identified by Sera from K18-hACE2 Mice Infected with the WT or Variant Viruses
Y Levy, R Alcalay, A Zvi, E Makdasi, E Peretz, T Noy-Porat, T Chitlaru, M Mandelboim, O Mazor, R Rosenfeld |
Human vaccines | 2022 |
|
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)
A Song, V Rocha, A Mendrone-Júnior, R Calado, G Santis, B Benites, C Costa-Lima, T Vargas, L Marques, J Fernandes, F Breda, S Wendel, R Fachini, L Rizzo, J Kutner, V Avelino-Silva, R Machado, E Durigon, S Chevret, E Kallas |
2022 | |
|
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
Wong TY, Horspool AM, Russ BP, Ye C, Lee KS, Winters MT, Bevere JR, Miller OA, Rader NA, Cooper M, Kieffer T, Sourimant J, Greninger AL, Plemper RK, Denvir J, Cyphert HA, Barbier M, Torrelles JB, Martinez I, Martinez-Sobrido L, Damron FH |
Journal of virology | 2022 |
|
The SARS-CoV-2 Antibodies, Their Diagnostic Utility, and Their Potential for Vaccine Development
Hajissa K, Mussa A, Karobari MI, Abbas MA, Ibrahim IK, Assiry AA, Iqbal A, Alhumaid S, Mutair AA, Rabaan AA, Messina P, Scardina GA |
Human vaccines | 2022 |
|
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Focosi D, Franchini M, Pirofski LA, Burnouf T, Paneth N, Joyner MJ, Casadevall A |
Clinical microbiology reviews | 2022 |
|
DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic
A Villa, E Brunialti, J Dellavedova, C Meda, M Rebecchi, M Conti, L Donnici, RD Francesco, A Reggiani, V Lionetti, P Ciana |
Pharmacological research : the official journal of the Italian Pharmacological Society | 2022 |
|
SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India
S Chunchu, U Ravula, V Gente, S Bacchu, S Rao, S Mooli |
Indian Journal of Hematology and Blood Transfusion | 2022 |
|
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
F Mohamed, D Anhlan, M Schöfbänker, A Schreiber, N Classen, A Hensel, G Hempel, W Scholz, J Kühn, E Hrincius, S Ludwig |
Pharmaceuticals (Basel, Switzerland) | 2022 |
|
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains
A de Souza, V de Freitas Amorim, G Guardia, F dos Santos, H Ulrich, P Galante, R de Souza, C Guzzo |
Viruses | 2022 |
|
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic.
|
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 |
|
Understanding the challenges to COVID-19 vaccines and treatment options, herd immunity and probability of reinfection
Al-Hatamleh MA, Abusalah MA, Hatmal MM, Alshaer W, Ahmad S, Mohd-Zahid MH, Rahman EN, Yean CY, Alias IZ, Uskoković V, Mohamud R |
Journal of Taibah University Medical Sciences | 2022 |
|
Investigation of SARS-CoV-2 Variants and Their Effect on SARS-CoV-2 Monoclonal Antibodies, Convalescent and Vaccine Plasma by a Novel Web Tool.
Arikan A, Sayan M |
2022 | |
|
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects.
Haveri A, Solastie A, Ekström N, Österlund P, Nohynek H, Nieminen T, Palmu AA, Melin M |
European Journal of Immunology | 2022 |
|
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
S Winklmeier, K Eisenhut, D Taskin, H Rübsamen, R Gerhards, C Schneider, PR Wratil, M Stern, P Eichhorn, OT Keppler, M Klein, S Mader, T Kümpfel, E Meinl |
iScience | 2021 |
|
Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
L Pirofski |
Clinical Infectious Diseases | 2021 |
|
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
SA Klassen, JW Senefeld, KA Senese, PW Johnson, CC Wiggins, SE Baker, N van Helmond, KA Bruno, L Pirofski, S Shoham, BJ Grossman, JP Henderson, RS Wright, DL Fairweather, NS Paneth, RE Carter, A Casadevall, MJ Joyner |
Frontiers in Medicine | 2021 |
|
Use of convalescent plasma in COVID ‐19 patients with immunosuppression
JW Senefeld, SA Klassen, SK Ford, KA Senese, CC Wiggins, BC Bostrom, MA Thompson, SE Baker, WT Nicholson, PW Johnson, RE Carter, JP Henderson, WR Hartman, L Pirofski, RS Wright, DL Fairweather, KA Bruno, NS Paneth, A Casadevall, MJ Joyner |
Transfusion | 2021 |
|
SARS-CoV-2 infection: molecular mechanisms of severe outcomes to suggest therapeutics
N Hartog, W Faber, A Frisch, J Bauss, CP Bupp, S Rajasekaran, JW Prokop |
Expert Review of Proteomics | 2021 |
|
Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
U Anand, S Jakhmola, O Indari, HC Jha, ZS Chen, V Tripathi, JM de la Lastra |
Frontiers in immunology | 2021 |
|
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex
J Tang, G Grubbs, Y Lee, C Huang, S Ravichandran, D Forgacs, H Golding, TM Ross, S Khurana |
EBioMedicine | 2021 |
|
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S |
iScience | 2021 |
|
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
KN da Silva, AL Gobatto, ZS Costa-Ferro, BR Cavalcante, AC Caria, LS de Aragão França, CK Nonaka, F de Macêdo Lima, M Lopes-Pacheco, PR Rocco, BS de Freitas Souza |
Stem Cell Research & Therapy | 2021 |
|
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
M Jiang, G Zhang, H Liu, P Ding, Y Liu, Y Tian, Y Wang, A Wang |
Frontiers in immunology | 2021 |
|
Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps
O Garraud, T Burnouf |
Transfusion Clinique et Biologique | 2021 |
|
Convalescent Plasma the Old Warhorse First to be Inducted in Pandemics is not the Zippy Chippy of Derby
S Sachdev, S Pathak, RR Sharma, M Mahapatra |
Indian Journal of Hematology and Blood Transfusion | 2021 |
|
International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary
AZ AlRiyami, T Burnouf, M Yazer, D Triulzi, LT Kumaş, L Sağdur, NB Pelit, R Bazin, SI Hindawi, MA Badawi, GK Patidar, HC Pandey, R Chaurasia, RM Fachini, P Scuracchio, S Wendel, AL Ang, KH Ong, P Young, J Ihalainen, A Vierikko, Y Qiu, R Yang, H Xu, N RahimiLevene, E Shinar, M Izak, CA Gonzalez, DM Ferrari, PV Cini, RN Aditya, RR Sharma, S Sachdev, R Hans, DS Lamba, LS NissenMeyer, DV Devine, CK Lee, JN Leung, IF Hung, P Tiberghien, P Gallian, P Morel, KA Maamari, Z AlHinai, H Vrielink, C SoOsman, VD Angelis, P Berti, A Ostuni, G Marano, MT Nevessignsky, ME Ekiaby, J Daly, V Hoad, S Kim, K Berg, M Vermeulen, TN Glatt, R Schäfer, R Reik, R Gammon, M Lopez, L Estcourt, S MacLennan, D Roberts, V Louw, N Dunbar |
Vox Sanguinis | 2021 |
|
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
D Focosi, F Maggi, M Franchini, S McConnell, A Casadevall |
International journal of molecular sciences | 2021 |
|
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan D |
medRxiv : the preprint server for health sciences | 2021 |
|
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF |
medRxiv : the preprint server for health sciences | 2021 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)